ASHLEY MCCORMACK: Open Payments
NPI 1003455361 · LEBANON, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,254 in 50 payments from 16 companies in 2025. Trend: 2023 $1,777 · 2024 $2,075 · 2025 $1,254
Food & beverage: $1,094Education: $160
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 12 | $333 |
| Novartis Pharmaceuticals Corporation | 7 | $165 |
| GENZYME CORPORATION | 4 | $119 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $98 |
| SANOFI-AVENTIS U.S. LLC | 1 | $85 |
| ABBVIE INC. | 3 | $70 |
| Galderma Laboratories, L.P. | 4 | $66 |
| Amgen Inc. | 3 | $56 |
| Regeneron Healthcare Solutions, Inc. | 3 | $55 |
| UCB, Inc. | 2 | $53 |
Products named: TREMFYA, DUPIXENT, COSENTYX, ILUMYA, SKYRIZI, NEMLUVIO, OTEZLA, Bimzelx.
Industry payments across TN — which companies pay providers there.
